Join
Live feed
·
NEWSReleasevia Quantisnow
Pluristem Therapeutics Inc. logo

UPDATE: Pluristem Reports Results From Its Phase III Study Did Not Meet The Primary Endpoint

ByQuantisnow·Wall Street's wire, on your screen.
PSTI· Pluristem Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTI (Pluristem Therapeutics Inc.) and more on Quantisnow.